Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup.

MLA

Waisbren, Susan E., et al. “Neurocognitive Assessment Platform for Clinical Trials in PKU: White Paper Developed by the NPKUA Neurocognitive Workgroup.” Molecular Genetics & Metabolism, vol. 143, no. 1/2, Sept. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.ymgme.2024.108555.

APA

Waisbren, S. E., Christ, S. E., Bilder, D. A., Bjoraker, K. J., Bolton, S., Chamberlin, S., Grant, M. L., Janzen, D. M., Katz, R., Lubliner, E., Martin, A., McQueen, K., Moshkovich, O., Nguyen-Driver, M., Shim, S., Stefanatos, A. K., Wilkening, G., & Harding, C. (2024). Neurocognitive assessment platform for clinical trials in PKU: White paper developed by the NPKUA neurocognitive workgroup. Molecular Genetics & Metabolism, 143(1/2), N.PAG. https://doi.org/10.1016/j.ymgme.2024.108555

Chicago

Waisbren, Susan E., Shawn E. Christ, Deborah A. Bilder, Kendra J. Bjoraker, Scout Bolton, Sarah Chamberlin, Mitzie L. Grant, et al. 2024. “Neurocognitive Assessment Platform for Clinical Trials in PKU: White Paper Developed by the NPKUA Neurocognitive Workgroup.” Molecular Genetics & Metabolism 143 (1/2): N.PAG. doi:10.1016/j.ymgme.2024.108555.